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Abstract
Congenital Adrenal Hyperplasia (CAH) is a familial disorder derived from reduction activity of enzymes in steroidogenesis process of the adrenal cortex that caused by a mutation of CYP21 gene located at 6p21.3. Prominent manifestation of CAH patients is ambiguity
on their genitalia.
This was a descriptive observational retrospective and prospective study following genetics, hormonal, and genital features from subjects with suspected CAH. Data was obtained using medical records from the Molecular and Cytogenetic Unit in Faculty of Medicine
Diponegoro University and cytogenetic laboratory of Telogorejo hospital in Semarang since April 2004 to April 2005. 
 Of the 79 patients diagnosed as ambiguous genitalia and hypospadia, 17 patients were suspected CAH and three of them were with mental retardation. Mutation analysis of CYP21 gene was done for 11 (64,7%) patients. Of the 8 cases (72,7%)
depicted common homozygous mutations (i.e. 163 bp del, IVS2-13A>G, K102R, S493N, I172N, R356W, S268T), 6 cases (75%) demonstrated other common heterozygote mutation. Interestingly, 3 patients had heterozygous mutations (i.e. one patient
with heterozygote Q318X, one with heterozygote V281L+920-921insT+Q381X and the other had heterozygote mutations I172N + R356 W all in 1 allele) manifested as simple virilizing CAH. The most frequent mutations were S493N (20%) followed
by IVS2-13A>G (15%) and I172N, R356W (14%) respectively. These frequencies are rather different than other published data in Caucasian population. Among those cases were found two familial cases, patients with suspect adrenal tumours, aromatase
deficiency and glucocorticoid receptor defect. Only 8 patients (47%) had specific hormonal values for CAH. Clinical stigmata were varies, however all patients developed enlarged clitoris.
Establishing physical examination alone is not effective in diagnosing CAH. Cytogenetic, hormonal assay and mutation analysis are essential for assessments.  
Keywords : ambiguous genitalia, congenital adrenal hyperplasia, CAH, CYP21 gene
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Abstrak
Kongenital Adrenal Hiperplasia (HAK) merupakan kelainan familial yang disebabkan oleh menurunnya aktivitas enzim yang berperan pada proses steroidogenesis di kelenjar adrenal oleh karena mutasi pada gen CYP21, terletak pada kromosom 6p21.3 yang mengkode
enzim- enzim tersebut. Ambiguitas pada kelamin merupakan manifestasi utama pasien HAK. 
Penelitian  ini  merupakan  penelitian  deskriptif  observasional  retrospektif  dan  prospektif  tentang  gambaran  distribusi  genetika,  hormon  dan  keadaan  kelamin  pasien  HAK.  Data  diambil  dari  catatan  medik  pada  unit  sitogenetik  dan  molekular  Fakultas  Kedokteran
Universitas Diponegoro dan laboratorium sitogenetik rumah sakit Telogorejo Semarang periode April 2004 sampai April 2005. 
Dari 79 pasien ambigus genitalia dan hipospadia, 17 diantaranya merupakan pasien HAK dan tiga (17,65%) dari  mereka adalah pasien HAK dengan retardasi mental. Sekuensing DNA pada gen CYP21 dilakukan pada 11 (64,70%) pasien. Dari 8 (72,72%) pasien  yang
menggambarkan mutasi homozigot (163 bp del, IVS2-13A>G, K102R, S493N, I172N, R356W, S268T), enam diantaranya (75%) ternyata juga memiliki mutasi heterezigot lain. Hal yang menarik adalah ditemukannya 3 pasien yang memiliki mutasi heterozigot (satu pasien
dengan mutasi heterozigot Q318X, satu pasien dengan mutasi heterozigot V281L+ 920-921insT +Q318X dan yang lain dengan mutasi heterozigot I172N dan R356W ketiganya  pada 1 alel) yang menunjukkan HAK tipe virilisasi sederhana. Mutasi yang paling sering terjadi
adalah mutasi pada S493N sebanyak 20% diikuti IVS2-13A>G sebanyak 15%, I172N dan R356W sebanyak 14%.  Hasil ini sedikit berbeda dari data frekuensi mutasi pada orang Kaukasia. Kasus menarik yang lainnya adalah adanya 2 kasus HAK familial, pasien dengan
kecurigaan tumor kelenjar adrenal, defisiensi aromatase, dan defek pada reseptor glukokortikoid. Delapan pasien (47,06%) memiliki gambaran hormon yang spesifik untuk HAK. Semua pasien menunjukkan pembesaran clitoris. 
Pemeriksaan fisik saja tidak efektif untuk mendiagnosa HAK. Pemeriksaan sitogenetik, hormon, dan analisa mutasi penting sebagai  pemeriksaan lanjut.
ii
Kata kunci : ambigus genitalia, congenital adrenal hyperplasia, CAH, gen CYP21
ii
TABLE OF CONTENT
      Sheet of title……………………………………… ............................... ……… i     
      Sheet of approval……………………………… ................................... ……….   ii
      Table of content………………………………. .................................... ……… iii      
      Abstract…………………………………….. ........................................ ……… iv
      Introduction……………………………………. ................................... ……… 1
      Subjects and Method …………………………….. ............................... ……… 3
      Results…………………………………………. ................................... ……… 3
      Discussion……………………………………….. ................................ ........... 8
     Acknowledgement……………………………………. ......................... .......... 13
      References……………………………………. .....................................  ......... v
Appendix I ……………………………………………………………………. vii
    
   
Introduction
Congenital Adrenal Hyperplasia (CAH) is autosomal recessive disorder caused by reduced activity of enzymes required for steroidogenesis in the adrenal cortex.1 This group of diseases is due to mutations in the genes encoding several enzymes
needed for the production of adrenal cortex hormones.2 CAH comprises the most frequent cause of ambiguous genitalia in the newborn, almost 60 % of all intersexes cases. It produces a female pseudohermaphroditism, a genital female with virilized
phenotype.3 
21-Hidroxylase deficiencies become the most common cause of CAH, 90% of all CAH cases. This occurs in two forms: classical and non-classical.  The classical form has two types: Salt  wasting (SW), and Simple Virilizing (SV) type. The
second most common cause of CAH (5-8%) of all CAH cases is the 11-β hydroxylase enzyme deficiency. Less other common cause of CAH is deficiencies of the following enzyme: 3-Beta-hydroxysteroid dehydrogenase; Aldosterone synthase; 17-α
hydroxylase deficiency; and mutations in the steroidogenic acute regulatory (StAR) protein.4
Clinical manifestation of CAH is different in male to that in female. Accelerated height, premature masculinization, and precocious sexual hair appear in childhood are features, that commonly found in male patients. While female patients, are
more jeopardized by inappropriate sex assignment, making the genitalia may appear more masculine. The clitoris is enlarged resembling a small penis. The cleft between the labia may be partly closed over (fusion of the labia majorae) hiding the entrance
to the vagina. Sometimes only one opening can be seen. 5,23 In classical CAH, there is prenatal virilization of external genitalia in females graded according to severity into Prader stages I-V. There is also progressive postnatal virilization in both sexes
including accelerated growth and advancement of bone age during the first years of life lead to early epiphyseal closure. Non- classic, milder forms of CAH, includes precocious pubarche in children and acne, hirsutism, and menstrual irregularities in
women.17 Problems that follow patients with CAH are involving medical aspects as well as psychosexual aspects. Salt wasting nephropathy occurs in 75% of infants born with CAH. Several types of tumours (adrenal, testicular, and pituitary) tend to
develop in some CAH patients. If it goes unrecognized, hypotension may happen and cause collapse. Some patients can be admitted to hospital for developing cerebral atrophy, spastic cerebral palsy and seizures. McGuire and Ommen in 1975 found
indication that  CAH patients do not have higher IQs than expected from family background. This is  also similar to  what  Wenzel  et  al,  1978 discovered.  There  is  even a  case report  about  CAH patients  with  severe  mental  retardation.  However,  the
correlation between mental retardation in CAH patients is still not well understood. 12
Clinical manifestation, hormonal, and analysis of mutations on related genes encoding enzyme of steroidogenesis process are decisive for diagnosing CAH patients. In clinical data, we can see ambiguous genitalia as the main appearance of CAH
cases primarily in female patients. Elevation of progesterone, 17-OH progesterone, and testosterone and decrease of cortisol and aldosterone are prominent hormonal features of CAH. Definite diagnosis of CAH is established by having cytogenetics and
molecular analysis. A karyotype of 46, XX must be found on patients with CAH, since most CAH patients who come to doctor are usually female. Male cases are usually asymptomatic. 17 
CYP21  gene,  located  on  short  arm  of  chromosome  6  (6p21.3)  is  a  cytochrome  P450  enzyme  located  in  the  endoplasmic  reticulum  and  which  catalyzes  the  conversion  of  17-hydroxyprogesterone  to  11-deoxycortisol  and  progestene  to
deoxycorticosterone.16 Mutations are related with deletion and gene conversion on CYP21 gene.13, 15 There were many well known mutation on CYP21 related to CAH cases i.e 163 bp del, IVS2-13A>G, K102R, S493N, I 172N, R 356W, P 30L, Q 318X,
R 102 K.20,21,24
Unfortunately the CAH data in Indonesia is scanty, probably because many of the patients and medical personnel are less aware to seek medical treatment making majority of CAH cases are under diagnosed and maltreated. Moreover most of the
patients come from low socio-economic background that cannot afford the cost for examination and therapy. This has been worsening by the lack of facilities required for diagnosing CAH cases. 
There are  two genetics  laboratories  in  Semarang,  Cytogenetics  Laboratory in  Telogorejo  Hospital  and the  Molecular  and Cytogenetics  laboratory in  Faculty of  Medicine.  Since the establishment  of  those laboratories  in  1999,  the  CAH cases
increase progressively. Presence the sexual adjustment team of Dr. Kariadi hospital as referral hospital dealing with ambiguous genitalia in Central Java makes the diagnosis of CAH improved significantly. 
This research aim is to know the distribution of genetics, hormonal, and physical features of CAH patients recorded in Cytogenetics laboratories in Semarang since April 2004 to April 2005. 
Subjects and Methods
Subjects
Subjects for this  research are all  ambiguous genitalia patients suspected for CAH examined in two cytogenetics laboratories in  Semarang.  Target  populations  are  all  ambiguous  genitalia  patients  diagnosed as  CAH clinically,  hormonally  and
genetically. This research was using a secondary data from medical records of CAH patients during period of April 2004- April 2005. Data was obtained from physical examination, hormonal assay, cytogenetic and mutation analysis. Some of hormonal
measurement and mutation analysis could not be examined in Indonesia due to financial reason.
Methods
This was a descriptive-observational retrospective and prospective study research. This research has been conducted in two places: Cytogenetics and Molecular of Biotechnology Laboratory of Medical Faculty of Diponegoro University Semarang
and Cytogenetics Laboratory of Telogorejo Hospital Semarang. The sampling collection was done in the period from April 2004 to April 2005 for ambiguous genitalia patients diagnosed as CAH clinically,hormonally, and genetically.  
Patients suspected for CAH, then examined for further investigation. Physical examination specifically designs for CAH was done i.e. Quigley stage, Prader stage, urethrogenital swelling, phallus length, chordae, and presence of secondary sexual
sign. Gender type, pedigree and photograph on genitalia were also recorded. Heparinized and EDTA peripheral blood was drawn for chromosome and DNA studies. Cytogenetic examination was performed using chromosome G banding procedure.27. 
The next step was to extract DNA from leucocytes using salting out method as elsewhere.25,26  Subsequent DNA and plasma were sent to Erasmus Medical Centre for hormonal analysis and mutation analysis.
Data processing on physical measurement and result of cytogenetic analysis was analyzed with descriptive method. The result of data processing was reported in table and chart.
Results
79 patients  diagnosed as  ambiguous genitalia  and hypospadia  since April  2004 to  April  2005,  with  CAH cases  accounted 17 out  of  79 ambiguous genitalia  and  hypospadia  cases  and  three  (17,65%)  of  them were  CAH patients  with  mental
retardation. Followings are their hormonal, mutation analysis and physical examinations.
Table 1. Overview of hormonal values mutation analysis and genital features conducted on 17 CAH patients . 
No Age PGN OP17 TSN ADIN COR Mutation  Gender Q S P S Enlarged Clitoris(> 2cm) Labio scrotal fusion
       Allele 1 Allele2      
1 33 N N ↑ ↑ ↓ − − F IV II + Fusion labia minora 
2 17 ↑ ↑ ↑ ↑ N 16 3bpdel 16 3bpdel M II IV + Fusion  labia majora  
       IVS2-13A>G IVS2-13A>G     
       K102R K102R     
       S493N S493N     
3 11 ↑ ↑ ↑ ↑ N I172N I172N F V I + Fusion labia minora 
       S493N      
4 21 ↑ N ↓ ↓ ↓ I172N F >VI normal female + No fusion
       R356W      
5 11 ↑ ↑ ↑ ↑ N P30L  F III III +  Fusion  labia majora
       R356W R356W     
6 33 ↑ ↑ ↑ ↑ ↓ I 172N  F III III + No fusion
       R356W      
       S493N S493N     
7 6 ↑ ↑ ↑ ↑ N Q318X  F III III + Labia majora fusion 
8 7 ↑ ↑ ↑ ↑ ↓ R356W R356W F II III + Fusion labia majora 
9 7 ↑ ↑ ↑ ↑ ↓ I172N I172N F V IV + Fusion  labia minora 
ii
       S493N      
10 4 ↑ ↑ ↑ ↑ ↓ IVS2-13A>G IVS2-13A>G F IV I + Fusion labia minora
       R102K      
       S268T S268T     
       Q318X      
11 3 ↑ ↑ ↑ ↑ ↓ 16 3bpdel 16 3bpdel F IV II + No fusion
       IVS2-13A>G IVS2-13A>G     
       K102R      
       S493N S493N     
12 1.5 ↑ ↑ ↑ ↑ ↓ − − F III II + Fusion labia majora 
13 4w ↑ ↑ ↑ ↑ ↑ − − F IV NE + Fusion labia majora 
14 8 N N ↓ ↓ ↓ V281L F II NE + Fusion labia majora 
       920-921insT     
       Q318X     
15 4w ↑ ↑ ↑ ↑ N − − F III NE + Fusion labia majora 
16 1.9 ↑ ↑ ↑ ↑ ↓ − − F V NE + Fusion labia majora 
17 10 ↑ ↑ ↑ ↑ ↓ − − F IV NE + No fusion
All cases were female gender with karotyping 46,XX except case no 2 were male with 46,XX karotyiping.  Patients with bold fonts were CAH patients with mental retardation
↑ :  Increase ↓ : Decrease N: normal   QS : Quigley stage         PS : Prader stage
Five different hormones were examined as parameters for CAH: Progesterone, 17-Hydroxyprogesterone, Testosterone, Androstenedione, and Cortisol. 
Distribution of hormonal values of 17 patients diagnosed as CAH can be seen below. 
HORMONAL OVERVIEWS OF 17 PATIENTS DIAGNOSED CAH 
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Fig.1. Distribution of each hormonal measured.
Note:
Prog   : Progesterone ADIN : Androstenedione 
OP-17 P: 17- Hydroxy Progesterone COR : Cortisol
TSN  : Testosterone
Hormonal  analysis  done in  Rotterdam illustrated that  17 patients  examined for  progesterone hormone:  15 patients  (88,  24%) showed elevation;  2  (11,  76%)  were  in  normal  values.  For  17-hydroxyprogesterone:  14  patients  (82,35%)  showed
elevation; 
3 patients were in normal values (17,64%). 15 patients (88, 24%) showed elevation, with 2 of them (11, 76%) showed decrease for both testosterone and androstenedione hormone. For cortisol hormone: 1(5, 88%) showed elevation; 5 (29, 41%) were in
normal values; 11 (64, 71%) showed decrease.
Increasing progesterone, 17-hydroxyprogesterone, testosterone, androstenedione and decreasing cortisol were found in 8 patients (47, 06%) from 17 suspected CAH. Aldosterone was not measured in this research. 
Of 17 suspected CAH patients, 11 (64,70%) patients were analysed for CYP21 gene mutation. Common homozygous mutations (i.e. 163 bp del, IVS2-13A>G, K102R,
S 493N, I 172N, R 356W, S 268T) were found in 8 (72,72%) cases. Six (75%) of whom also demonstrated other heterozygote mutation (i.e. compound heterozygote for I172N+S 493N / I172N; P30L+R356W / R356W; I172N+R356W+S493N / S493N;
 I 172N + S493N /  I  172N;  IVS2-13A>G+R102K+S268T+Q318X /  IVS2-13A>G+S 268T;  163 bp del+ IVS2-13A>G+K102R+S493N/163 bp del  +IVS2-13A>G+S493N).  Of 8  patients  (47,06%) demonstrated specific  hormonal  values  for  CAH,  5
(29,41%)  had  confirmed  mutation  on  CYP21  gene.  Interestingly,  3  patients  depicted  heterozygous  mutations  (i.e.  one  patient  with  heterozygote  mutation  Q318X,  one  with  heterozygote  mutations  V281L+920-921insT+Q318X  and  the  other  had
heterozygote mutations I172N + R356W all in 1 allele) manifested as simple virilized CAH. The most frequent mutation was S493N (20%) followed by IVS2-13A>G (15%), I172N and R356W (14%) cases respectively. Distributions of mutations are as
described below. 
Fig.2. Distribution of mutations in CAH patients. 
This study revealed variations of clinical features from CAH patients primarily on their genitalia. Most of them had stage III for Quigley (35, 29%) and stage II for Prader (23, 53%). 64,71% of patients had labia majora and minora, 29,41% had
only labia major and 5,88% had scrotum bifidum. All of patients (100%) demonstrated enlarged clitoris more than 2 cm in length, particular sign for CAH. Below are results for physical examination.
Table 2. Results of physical examination in 17 CAH patients from April 2004- April 2005.
Clinical Examination Classification Total Patients Percentage
Gender Female 16 94,12%
 Male 1 5,88%
Quigley Stage I 0 0%
II 2 11,76%
 III 6 35,29%
 IV 5 29,41%
 V 3 17,65%
 >V 1 5,88%
Prader Stage Normal Female 1 5,88%
 I 2 11,76%
 II 4 23,53%
 III 3 17,65%
 IV 1 5,88%
 V 0 0%
 NE (Not Examined) 6 35,29%
Labia Majora and Minora Has Both 11 64,71%
 Only Labia Majora 5 29,41%
 Scrotum Bifidum with fusion labia majorae 1 5,88%
Labio fusion Fusion labia majora 9 52,94%
Fusion labia minora 4 23,53%
 Has no fusion 4 23,53%
Clitoris Enlarge (> 2 cm) 17 100%
ii
Chordae Negative  (-) 16 94,12%
 Positive   (+) 1 5,88%
Ending in perineal Two endings with introitus vaginae 11 64,71%
 Two endings with blind end vaginae 1 5,88%
 One ending 5 29,41%
Secunder sex sign  3 17,65%
at very young age    
    
Mental Retardation  3 17,65%
Discussion
Only  8  patients  with  specific  hormonal  values  for  CAH  while  the  rest  of  the  patients  showed  variation  in  hormonal  values,  they  might  have  increasing  testosterone  and  androstenedione  but  they  had  normal  level  of  progesterone  and
17-hydroxyprogesterone and vice versa. Some patients (e.g. patient no 4 and 7) received Prednison or Dexamethasone therapy nevertheless showing different cortisol level. 
Genetically, CAH patients express 46, XX karyotyping for female patients or 46, XY for male patients. In this research 16 out of 17 patients (94, 11%) suspected CAH showed karyotyping of 46, XX, which is apposite to their known gender,
female. But there was 1 patient (5, 55%) whose known gender is male with 46, XX karyotyping. 
There have been few reports regarding CYP21 gene mutations in Asian people.  A study of 28 Singaporean revealed that  the intron 2 mutation (IVS2-1A/C-G) was the most  common mutation followed by I172N and R356W.18  This result  is
consistent to what Usui et al, 2004 reported from 36 Japanese patients with CAH. 19 In contrast to the Caucasians, it was reported that the most common mutations in descending orders for British population are: large scale deletions/conversions, the
intron 2 splice mutation, R357W, and I172N. 20   Netherlands as many other western European countries has the same pattern of CYP21 gene mutation. The patterns showed the most common mutations are deletion/conversion followed by I2G, I172N,
and R356W21.  It was speculated that R356W mutation seems to occur more commonly in the Asian patients and less in Caucasian.19. Surprisingly in this study, the missense mutation S493N became the most frequent mutation followed by IVS2-13A>G,
I172N and R356W makes it slight different to the other published data. All of them result from gene conversion. 
The salt wasting or simple virilizing forms of CAH result  from IVS2-13A>G mutation,  is  reported to be the most  prevalent  mutation in the CYP21 gene among all  ethnic groups.  7  In 1988, Higashi et  al  identified this mutation results  from
aberrant splicing of I 2(conversion) involving the nucleotide no 656 A/C→G. According to Miller et al, 1996 this mutation is located in intron 2, 13 bases from the splice acceptor site of exon 3. Either a C-to-G or A-to-G mutation at nucleotide 13 causes
severe forms of 21-OH deficiency. White et al, 1994 mentioned that this mutation correspond to 22% of salt wasting cases, 25% of simple virilizing form, 12% of non classical cases. 
The simple virilizing form of CAH is often related to I172N mutation where there was a substitution at codon 172 that results in substitution of Isoleucin into Asparagine. 8,13 It is a missense mutation (conversion) of CYP21 gene that only affected
the structure, not the expression of the protein (Chiou et al, 1990) results in a defective enzyme (Amor et al, 1988). I172N mutation is related to wild type of 17-hydroxyprogesterone and Progesterone activity. 9, 10 According to Speiser et al, 1992 of 88
families with 21-OH deficiency 16% had this mutation, with 2% enzyme activity and a simple virilizing phenotype. 
The R356W mutation is associated with the non-classical type of 21-OH deficiency, where Arginine (Arg) 356 is replaced by Tryptophan. It is a missense mutation (conversion) results in radical Amino acid substitution (Chiou et al, 1990). 
In this research there was also found one heterozygous patient for mutation P30L, a substitution of Leucine for Proline at codon 30. P30L is also somewhat related to wild activity of 17-hydroxyprogesterone and Progesterone as much as 60% and
about 30% of normal activity for Progesterone. This type of mutation is presumed to be potentially giving effects to the non-classical type of 21-OH deficiency (Tusie et al, 1991).
 Glutamine is changed to stop codon in Q318X mutation. This may result in a completely non-functional enzyme due to premature termination of translation of the mRNA. A homozygous mutation for this gene results in salt wasting type of CAH,
while compound heterozygous mutation in this gene is associated with simple virilizing form (Kharat et al, 2004). Dracopoulou-Vabouli et al, 2001 found that P30L mutation is happened in 21,4% in the non-classical form from 111 unrelated subjects in
the Hellenic population.
163 bp del is best described as 3 base pairs deletion/insertion (Leu deletion/ insertion) downstream codon 9. As described in many literature insertion 3 base pairs CTG has no effect on the enzymatic activity, and it is assumed that such change is
a non-functional mutation (Rodriques et al, 1987)
Speiser et al, 1988 detected a change in codon 281 from GTG, encoding Valine, to TTG, encoding Leucine in 9 non-classical 21-OH deficiency patients. White et al, 1994 mentioned that 34% of all non-classical type is due to this mutation.
While Mornet et al, 1991 mentioned that the val-281-to-leu mutation accounts for 75 to 80% of non-classic 21-hydroxylase deficiency.
Other  mutations  found  were  K102R,  S493N  and  S268T.  Both  K102R  and  S493N  are  non-functional  mutation  (Rodriques  et  al,  1987).  While  it  can  be  inferred  that  S268T  mutation  is  non-functional  mutation,  which  does  not  cause  CAH
(Tusie-Luna et al, 1991)
Patient no 1, 33 year old girl was with virilization on her genitalia. Established hormonal measurement indicated normal level of progesterone, and 17-hydroxyprogesterone despite the increasing of testosterone, androstenedione and decreasing of
cortisol. There was no confirmation on CYP21 gene mutation; this can be understood since she had normal 17-hydroxyprogesterone, signifying no presence of mutation.   However there was an increasing testosterone, led to masculinization for her
genitalia. It is highly possible that she is suspect for adrenal tumour. But further investigation should be assessed to confirm the diagnosis. 
In three patients (patient no 4, 7, and 14), there was single heterozygote mutation but those patients manifested a simple virilized CAH. Patient no 4 was with heterozygote mutation I172+R356W; patient no 7 was with heterozygote mutation
Q318X while patient no 14 was with heterozygote mutation V281L+920-921insT+Q318X. It is very remarkable since theoretically a single heterozygote mutation will not clinically manifest CAH (CAH is autosomal recessive disorder). It is very likely
that in these patients have other mutation somewhere in the region that can cause these features. This was confirmed by the increasing of 17-hydroxyprogesterone (except for patient no 4 and 14, they showed normal level of 17-hydroxyprogesterone)
indicating presence of mutation. Other factors should be considered as part of the explanation since in most genetic cases environmental factors play a tribute role for the phenotypic of patients. Therefore further investigation should be done to confirm
this phenomenon.
Patient no 13, a month year old baby girl come with virilization on her genitalia. She depicted high level all measured hormones and remarkably high level of cortisol. There was no confirmation on CYP21 gene mutation. It is possible that she is
suffered from glucocorticoid receptor defect. 
Patient no 14, an 8-year-old girl with ambiguous genitalia, showing phenotype of CAH (clitoris enlarged- see fig. 3) but levels of 17-hydroxyprogesterone and androstenedione are relatively normal. This excludes a CYP21 block. But the cortisol
level  is  relatively  low.  Testosterone  is  below  detection  level,  despite  this  girl  had  no  steroid  therapy.  These  indicate  to  a  block  early  in  steroid  biosynthesis,  probably  at  the  level  of  cholesterol  side  chain  cleavage  or  the  StAR  protein.  The  other
consideration on explaining this feature is that this girl might suffer from aromatase deficiency. However another molecular analysis for this  patient  and her father also done in Nijmegen, and the result  is  that  she and her father shared same type of
heterozygote mutation V281L + 920-921 ins T +Q318X. Her mutation is  located at  the exact  same allele as her father.  Molecularly she and her  father  are  confirmed to  be carrier  CAH, but  this  does  not  explain  such phenotype on the genitalia  she
demonstrated. Therefore it is possible that other mutations are present on the other areas of the gene.
Two familial CAH cases were also found.  Patient no 3 (see fig.4) and no 9 were sisters with simple virilized of CAH. Both demonstrated the same compound heterozygote mutation of I 172N+ S493N / I72N. They were also having elevation of
progesterone, 17-hydroxy progesterone, testosterone and androstenedione although patient no 3 was having relatively normal level of cortisol while her sister had low level of cortisol. The other familial CAH cases were patient no 2 and no 11. Patient no
2 seemed to show a more severe form of virilization. It is quite understandable since she  (patient no.2) demonstrated more frequency of homozygote mutation compare to her sister. As the other CAH family case, these patients also had same pattern of
elevation of progesterone, 17-hydroxy progesterone, testosterone and androstenedione despite patient no 2 was having relatively normal level of cortisol while her sister had low level of cortisol.
The exposure of androgen in both classical CAH and nonclassical 21-hydroxylase deficiencies may cause acelerated linear growth velocity and diminished final height in both males and females.6 This is similar to 3 of our cases (patient no2, 4 and
6) that displayed an adult short stature. Patient no 2, 17 year old girl with severe virilization CAH was having final height 145,5 cm. Patient no 4 is 21 year old girl with simple virilization CAH was having final height of 150 cm. While patient no 6 is 33
year old girl also manifested  simple virilization CAH with final height of 149,5 cm.
ii
Many variations were found in the physical examination of patients, therefore physical features could not be used alone in establishing the diagnosis. Other examination such as hormonal assays and mutation analysis of CYP21 gene is needed.
Conversely most patients were from low socio economic level that they could not afford the cost of laboratory examination and therapy as well.
A cytogenetics laboratory is necessary to perform the genotype of ambiguous genitalia patients, but this laboratory only available in 4 cities in Java island for whole archipelago with the population about 220 million. Patients from rural areas who
may have ambiguous genitalia can be barely detected. It results in the diagnosis of CAH is neither yet well-established nor well detected and lead to incorrect treatment.
Issues about ambiguous genitalia and CAH in Indonesia up to now are less popular around medical personnel and even in the community. There was an increasing tendency of ambiguous genitalia patients seek for medical treatment during the
progress of this research. Unfortunately, most of them came late, this made the further management and therapies more complicated. The delay of CAH patients admitted to hospital causes some of them develop more complex abnormalities such as
seizures, cerebral atrophy, cerebral palsy, or mental retardation. 
Thus, it is suggested to conduct other research to provide a better understanding about CAH, prevalence of CAH in Indonesia and give new insight into the underlying process.
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List of Abreviations
1. CAH  : Congenital Adrenal Hyperplasia
2. StAR            :  Steroid Acute Regulatory Protein
3. bp                 : base pairs
4. del                : deletions
5. IVS2  : interfering sequence 2
6. ins  : insertion
7. A                  : nucleic acid code for adenine
8. G  : nucleic  acid code for guanine
9.  I                   : amino acid code for isoleucine
10. K  : amino acid code for lysine
11.L                  : amino acid code for leucine
12.N                 : amino acid code for asparagine
13.P  : amino acid code for proline
14.Q  : amino acid code for glutamine
15. R                : amino acid code for arginine
16.S                 : amino acid code for serine
17. T  : amino acid code for threonine
18. V  : amino acid code for valine
19.W               : amino acid code for tryptophan
20.X               : stop codon (TAG or TAA)
